$BNGO
Bionano Genomics, Inc. Stock $bngo

$bngo Overview Financials Valuation SEC Filings Company Website

2019 Q3 Form 10-Q Financial Statement

#000162828019010447 Filed on August 08, 2019

Income Statement

Concept	2019 Q3	2019 Q2	2018 Q2
Revenue	$3.313M	$2.175M	$3.390M
YoY Change	17.12%	-35.84%	54.36%
Cost Of Revenue	$2.375M	$1.555M	$1.813M
YoY Change	-22.6%	-14.25%	10.65%
Gross Profit	$938.0K	$620.0K	$1.577M
YoY Change	-491.44%	-60.67%	182.92%
Gross Profit Margin	28.31%	28.51%	46.51%
Selling, General & Admin	$4.449M	$5.056M	$3.490M
YoY Change	37.99%	44.87%	-10.97%
% of Gross Profit	474.31%	815.48%	221.36%
Research & Development	$2.174M	$2.408M	$2.099M
YoY Change	-13.22%	14.73%	-38.09%
% of Gross Profit	231.77%	388.39%	133.13%
Depreciation & Amortization	$278.2K	$267.0K	$387.1K
YoY Change	-28.9%	-31.04%	4.62%
% of Gross Profit	29.66%	43.06%	24.55%
Operating Expenses	$6.623M	$7.464M	$5.589M
YoY Change	15.6%	33.55%	-23.65%
Operating Profit	-$5.685M	-$6.844M	-$4.012M
YoY Change	-4.76%	70.58%	-40.67%
Interest Expense	$578.0K	$645.0K	$407.6K
YoY Change	42.91%	58.23%	-391.17%
% of Operating Profit
Other Income/Expense, Net	-$709.0K	-$816.0K	$706.3K
YoY Change	-168.19%	-215.54%	194.27%
Pretax Income	-$6.394M	-$7.660M	-$3.306M
YoY Change	29.72%	131.7%	-50.44%
Income Tax	$4.000K	$5.000K	$5.506K
% Of Pretax Income
Net Earnings	-$6.398M	-$7.665M	-$3.311M
YoY Change	29.88%	131.47%	-149.61%
Net Earnings / Revenue	-193.12%	-352.41%	-97.68%
Basic Earnings Per Share
Diluted Earnings Per Share	-$587.2K	-$705.3K	-$348.8K
COMMON SHARES
Basic Shares Outstanding	10.90M shares	10.85M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q3	2019 Q2	2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.200M	$15.30M	$7.600M
YoY Change	-60.39%	101.32%
Cash & Equivalents	$8.200M	$15.29M	$7.624M
Short-Term Investments
Other Short-Term Assets	$695.2K	$465.5K	$3.200M
YoY Change	-36.73%	-85.45%
Inventory	$2.595M	$3.022M	$2.000M
Prepaid Expenses
Receivables	$6.001M	$4.984M	$2.900M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$17.84M	$23.93M	$15.70M
YoY Change	-37.67%	52.43%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.368M	$1.279M	$2.400M
YoY Change	-33.25%	-46.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.368M	$1.279M	$2.400M
YoY Change	-33.25%	-46.71%
TOTAL ASSETS
Total Short-Term Assets	$17.84M	$23.93M	$15.70M
Total Long-Term Assets	$1.368M	$1.279M	$2.400M
Total Assets	$19.21M	$25.21M	$18.10M
YoY Change	-37.37%	39.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.634M	$3.618M	$1.800M
YoY Change	11.44%	100.99%
Accrued Expenses	$3.432M	$2.702M	$4.500M
YoY Change	21.91%	-39.96%
Deferred Revenue	$417.9K	$421.3K
YoY Change
Short-Term Debt	$1.000M	$800.0K	$14.30M
YoY Change		-94.41%
Long-Term Debt Due			$0.00
YoY Change
Total Short-Term Liabilities	$7.437M	$7.541M	$22.40M
YoY Change	34.86%	-66.33%
LONG-TERM LIABILITIES
Long-Term Debt	$18.78M	$18.62M	$9.000M
YoY Change	108.44%	106.91%
Other Long-Term Liabilities	$147.1K	$173.8K	$1.000M
YoY Change	-80.82%	-82.62%
Total Long-Term Liabilities	$18.92M	$18.80M	$10.00M
YoY Change	93.59%	87.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.437M	$7.541M	$22.40M
Total Long-Term Liabilities	$18.92M	$18.80M	$10.00M
Total Liabilities	$26.59M	$26.56M	$32.40M
YoY Change	72.25%	-18.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$94.68M	-$88.28M
YoY Change	42.69%
Common Stock	$87.30M	$86.93M
YoY Change	7.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$7.379M	-$1.345M	-$57.28M
YoY Change
Total Liabilities & Shareholders Equity	$19.21M	$25.21M	$18.10M
YoY Change	-37.37%	39.29%

Cashflow Statement

Concept	2019 Q3	2019 Q2	2018 Q2
OPERATING ACTIVITIES
Net Income	-$6.398M	-$7.665M	-$3.311M
YoY Change	29.88%	131.47%	-149.61%
Depreciation, Depletion And Amortization	$278.2K	$267.0K	$387.1K
YoY Change	-28.9%	-31.04%	4.62%
Cash From Operating Activities	-$7.180M	-$6.320M	-$2.960M
YoY Change	17.7%	113.51%	-40.56%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K	-$30.00K	-$180.0K
YoY Change	-92.31%	-83.33%	-53.85%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$10.00K	-$30.00K	-$180.0K
YoY Change	-92.31%	-83.33%	-53.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	120.0K	810.0K	3.220M
YoY Change	-99.38%	-74.84%	-48.48%
NET CHANGE
Cash From Operating Activities	-7.180M	-6.320M	-2.960M
Cash From Investing Activities	-10.00K	-30.00K	-180.0K
Cash From Financing Activities	120.0K	810.0K	3.220M
Net Change In Cash	-7.070M	-5.540M	80.00K
YoY Change	-154.26%	-7025.0%	-90.91%
FREE CASH FLOW
Cash From Operating Activities	-$7.180M	-$6.320M	-$2.960M
Capital Expenditures	-$10.00K	-$30.00K	-$180.0K
Free Cash Flow	-$7.170M	-$6.290M	-$2.780M
YoY Change	20.1%	126.26%	-39.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	bngo	Fair Value Of Stock Issued With Debt Classified As Liability FairValueOfStockIssuedWithDebtClassifiedAsLiability	0	USD
	bngo	Fair Value Of Stock Issued With Debt Classified As Liability FairValueOfStockIssuedWithDebtClassifiedAsLiability	201789	USD
	bngo	Accretion Of Debt Discount AccretionOfDebtDiscount	-60655	USD
	bngo	Accretion Of Debt Discount AccretionOfDebtDiscount	-128518	USD
CY2018Q4	bngo	Annual Future Minimum Royalty Payments AnnualFutureMinimumRoyaltyPayments	90000	USD
	bngo	Debtissuancecostsincurredbutnotpaid Debtissuancecostsincurredbutnotpaid	129474	USD
	bngo	Debtissuancecostsincurredbutnotpaid Debtissuancecostsincurredbutnotpaid	0	USD
	bngo	Deferredequityissuancecostsinaccountspayableandaccruedliabilities Deferredequityissuancecostsinaccountspayableandaccruedliabilities	1401350	USD
	bngo	Deferredequityissuancecostsinaccountspayableandaccruedliabilities Deferredequityissuancecostsinaccountspayableandaccruedliabilities	0	USD
	bngo	Employee Stock Purchase Plan Compensation Expense EmployeeStockPurchasePlanCompensationExpense	0	USD
	bngo	Employee Stock Purchase Plan Compensation Expense EmployeeStockPurchasePlanCompensationExpense	102815	USD
	bngo	Fair Value Of Warrants Issued With Debt Classified As Liability FairValueOfWarrantsIssuedWithDebtClassifiedAsLiability	176813	USD
	bngo	Fair Value Of Warrants Issued With Debt Classified As Liability FairValueOfWarrantsIssuedWithDebtClassifiedAsLiability	629830	USD
	bngo	Final Payment Fee Due In Connection With Repayment Of Debt Classified Within Other Long Term Liabilities FinalPaymentFeeDueInConnectionWithRepaymentOfDebtClassifiedWithinOtherLongTermLiabilities	400000	USD
	bngo	Final Payment Fee Due In Connection With Repayment Of Debt Classified Within Other Long Term Liabilities FinalPaymentFeeDueInConnectionWithRepaymentOfDebtClassifiedWithinOtherLongTermLiabilities	0	USD
CY2018Q1	bngo	Long Term Debt Prepayment Fees LongTermDebtPrepaymentFees	0	USD
	bngo	Long Term Debt Prepayment Fees LongTermDebtPrepaymentFees	412000	USD
CY2019Q2	bngo	Operating Leases Future Minimum Payments Due Net OperatingLeasesFutureMinimumPaymentsDueNet	647236	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5162364	USD
CY2019Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5699166	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	82898775	USD
CY2019Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	86932839	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	201789	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	54444	USD
CY2019Q2	bngo	Operating Leases Future Minimum Payments Due Next Twelve Months Net OperatingLeasesFutureMinimumPaymentsDueNextTwelveMonthsNet	209158	USD
CY2019Q2	bngo	Operating Leases Future Minimum Payments Duein Two Years Net OperatingLeasesFutureMinimumPaymentsDueinTwoYearsNet	438078	USD
CY2018	bngo	Purchase Obligation Contract Termination Period PurchaseObligationContractTerminationPeriod	P90D
CY2018	bngo	Purchase Obligation Initial Purchase Period PurchaseObligationInitialPurchasePeriod	P2Y
	bngo	Transfer Of Instruments To Property And Equipment From Inventory TransferOfInstrumentsToPropertyAndEquipmentFromInventory	106617	USD
	bngo	Transfer Of Instruments To Property And Equipment From Inventory TransferOfInstrumentsToPropertyAndEquipmentFromInventory	0	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2019-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001411690
CY2019Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10897522	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Bionano Genomics, Inc.
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1351736	USD
CY2019Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3617836	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4514333	USD
CY2019Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4983510	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2900129	USD
CY2019Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2702015	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	76224	USD
CY2019Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	85997	USD
CY2018Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	119630	USD
CY2019Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	58795	USD
CY2018Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	52982	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	289395	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	335666	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	629830	USD
CY2018Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	52981	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	107426	USD
CY2019Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	335666	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	625061	USD
CY2018Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	48461	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	69791	USD
CY2019Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	79388	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	128518	USD
CY2019Q2	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	56263	USD
	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	112526	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4137031	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5941213	shares
CY2018Q4	us-gaap	Assets Assets	24802421	USD
CY2019Q2	us-gaap	Assets Assets	25210868	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	23025119	USD
CY2019Q2	us-gaap	Assets Current AssetsCurrent	23931979	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	130484	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	8740	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16522729	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15294526	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1021897	USD
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7624289	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16522729	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15294526	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6602392	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1228203	USD
CY2018Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	6374148	shares
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10055072	shares
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10897522	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10055072	shares
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10897522	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	1004	USD
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	1088	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	270998	USD
CY2019Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	421342	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	304467	USD
CY2019Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	219202	USD
CY2019Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	0	USD
CY2018Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1813430	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2654879	USD
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1555246	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1953533	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2702288	USD
CY2018Q2	us-gaap	Costs And Expenses CostsAndExpenses	5588800	USD
	us-gaap	Costs And Expenses CostsAndExpenses	10851297	USD
CY2019Q2	us-gaap	Costs And Expenses CostsAndExpenses	7463697	USD
	us-gaap	Costs And Expenses CostsAndExpenses	14354410	USD
CY2018Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	387104	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	778555	USD
CY2019Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	266963	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	536802	USD
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.98
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.37
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.71
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.47
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0013
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0006
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1832630	USD
CY2019Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1553276	USD
CY2019Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3300000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y8M12D
CY2018Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1517723	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2470921	USD
CY2019Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2018Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-342164	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-342164	USD
CY2019Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-921496	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3305970	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7149556	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7660080	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15507337	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5506	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9282	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4486	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8972	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1058391	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2257359	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-228009	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	469177	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	49359	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-367628	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	172578	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	697361	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-287647	USD
CY2018Q2	us-gaap	Interest Expense InterestExpense	407635	USD
	us-gaap	Interest Expense InterestExpense	709616	USD
	us-gaap	Interest Expense InterestExpense	838392	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	907089	USD
CY2019Q2	us-gaap	Interest Expense InterestExpense	565888	USD
CY2019Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2113335	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	1068557	USD
CY2019Q2	us-gaap	Inventory Net InventoryNet	3022090	USD
CY2018Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	161468	USD
CY2019Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	908755	USD
CY2018Q4	us-gaap	Liabilities Liabilities	14665070	USD
CY2019Q2	us-gaap	Liabilities Liabilities	26555678	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24802421	USD
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25210868	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4522863	USD
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7541008	USD
CY2018Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2019Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	799815	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	9029374	USD
CY2019Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	18621696	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16545714	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11669871	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-189401	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29649	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9753921	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19900000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12868425	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-3847362	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-3311476	USD
	us-gaap	Net Income Loss NetIncomeLoss	-7158838	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-7851743	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-7664566	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15516309	USD
CY2018Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	706251	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1198126	USD
CY2019Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-815772	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2478020	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4012221	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8347682	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6844308	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13029317	USD
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1333740	USD
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	902412	USD
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	686504	USD
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Receivable Current OperatingLeasesFutureMinimumPaymentsReceivableCurrent	222170	USD
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	464334	USD
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	431328	USD
CY2019Q2	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	105529	USD
	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	211058	USD
CY2018Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	147522	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	295044	USD
CY2019Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	42949	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	85898	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	871645	USD
CY2019Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1003947	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1012	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	65060	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4465919	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2407692	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2409593	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	7447571	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1105745	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	10812000	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2098826	USD
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	384131	USD
CY2019Q2	us-gaap	Other Assets Current OtherAssetsCurrent	465511	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	808366	USD
CY2019Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	173772	USD
CY2018Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	61673	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	221015	USD
CY2019Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	249884	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	718132	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	0	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	166524	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	189401	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	29649	USD
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	919500	USD
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	631853	USD
CY2018Q4	us-gaap	Prepaid Insurance PrepaidInsurance	460684	USD
CY2019Q2	us-gaap	Prepaid Insurance PrepaidInsurance	166342	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	14329843	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	9662430	USD
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	19207403	USD
	us-gaap	Profit Loss ProfitLoss	-7158838	USD
	us-gaap	Profit Loss ProfitLoss	-15516309	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6939666	USD
CY2019Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6978055	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1777302	USD
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1278889	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	238000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2018Q4	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	165000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	305930	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4507803	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-72762428	USD
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-88278737	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	53976	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3390009	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5158494	USD
CY2018Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	707	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2174635	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4027381	USD
	us-gaap	Royalty Expense RoyaltyExpense	74580	USD
	us-gaap	Royalty Expense RoyaltyExpense	58795	USD
CY2018Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3489974	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6385378	USD
CY2019Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5056005	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9846607	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	107426	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	625061	USD
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.630
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.025
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.020
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.024
CY2018Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2019Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y4M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	66155	shares
CY2019Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	102815	USD
CY2019Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2409593	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	305	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11084	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-50227211	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	-54019824	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	-57277611	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	10137351	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	5870191	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	-1344810	USD
CY2018Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.5
CY2018Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0467
CY2018Q4	us-gaap	Supplies Supplies	74685	USD
CY2019Q2	us-gaap	Supplies Supplies	0	USD
CY2018Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	3364128	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	5227448	shares
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	10860055	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	10541563	shares

Files In Submission

Name	View Source	Status
0001628280-19-010447-index-headers.html	Edgar Link	pending
0001628280-19-010447-index.html	Edgar Link	pending
0001628280-19-010447.txt	Edgar Link	pending
0001628280-19-010447-xbrl.zip	Edgar Link	pending
bngo-20190630.xml	Edgar Link	completed
bngo-20190630.xsd	Edgar Link	pending
bngo-20190630x10q.htm	Edgar Link	pending
bngo-20190630xexx101.htm	Edgar Link	pending
bngo-20190630xexx311.htm	Edgar Link	pending
bngo-20190630xexx312.htm	Edgar Link	pending
bngo-20190630xexx321.htm	Edgar Link	pending
bngo-20190630_cal.xml	Edgar Link	unprocessable
bngo-20190630_def.xml	Edgar Link	unprocessable
bngo-20190630_lab.xml	Edgar Link	unprocessable
bngo-20190630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BNGO
Bionano Genomics, Inc. Stock $bngo

2019 Q3 Form 10-Q Financial Statement

#000162828019010447 Filed on August 08, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNGO Bionano Genomics, Inc. Stock $bngo

2019 Q3 Form 10-Q Financial Statement

#000162828019010447 Filed on August 08, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNGO
Bionano Genomics, Inc. Stock $bngo